Roche announces full FDA approval for Venclexta combinations for acute myeloid leukaemia

    NEXT STORY
    Amryt and Swixx Sign Distribution Deal for Lojuxta
    PREV STORY
    ATEC Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Diffusion Pharmaceuticals Establishes Scientific Advisory Board

    CHARLOTTESVILLE, Va., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical ...

    author_avatar
    NASDAQ Market News

    Flexion Therapeutics Presents Updated Results from Clinical Trial Evaluating Repeat Administration of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) at Osteoarthritis Research Society International World Congress

    author_avatar
    NASDAQ Market News

    Chiasma Reports Second Quarter 2017 Results

    WALTHAM, Mass., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a clinical-stage biopharmaceutical ...

    author_avatar
    NASDAQ Market News